Actively Recruiting
Long-term Safety Trial with NVDX3
Led by Novadip Biosciences · Updated on 2024-09-05
15
Participants Needed
1
Research Sites
601 weeks
Total Duration
On this page
Sponsors
N
Novadip Biosciences
Lead Sponsor
P
PrimeVigilance
Collaborating Sponsor
AI-Summary
What this Trial Is About
An study evaluating the long-term safety of all patients previously treated with NVDX3.
CONDITIONS
Official Title
Long-term Safety Trial with NVDX3
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient being implanted with NVDX3.
- Previously participated to one of the NVDX3 core clinical trials.
- Patient accepts to comply to a yearly follow-up safety visit for 10 additional years
- Patient has understood and accepted to participate in the long-term follow-up study by signing the informed consent.
You will not qualify if you...
- No exclusion criteria are applicable.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de Luxembourg
Luxembourg, Luxembourg, 1210
Actively Recruiting
Research Team
D
Denis Dufrane, MD
CONTACT
D
Danielle Gérard, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here